| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia.
|
J Clin Oncol
|
2000
|
3.50
|
|
2
|
Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy.
|
Cancer
|
2001
|
2.59
|
|
3
|
Production of "authentic" poliovirus RNA-dependent RNA polymerase (3D(pol)) by ubiquitin-protease-mediated cleavage in Escherichia coli.
|
Protein Expr Purif
|
1999
|
2.24
|
|
4
|
Clinical course of solitary extramedullary plasmacytoma.
|
Radiother Oncol
|
1999
|
2.05
|
|
5
|
Solitary bone plasmacytoma: outcome and prognostic factors following radiotherapy.
|
Int J Radiat Oncol Biol Phys
|
1998
|
1.56
|
|
6
|
Non-Hodgkin's lymphomas involving the uterus: a clinicopathologic analysis of 26 cases.
|
Mod Pathol
|
2000
|
1.55
|
|
7
|
Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma.
|
Blood
|
1998
|
1.54
|
|
8
|
Lymphoma of the nasal cavity and paranasal sinuses: improved outcome and altered prognostic factors with combined modality therapy.
|
Cancer
|
1997
|
1.17
|
|
9
|
Localized primary malignant lymphoma of bone.
|
Int J Radiat Oncol Biol Phys
|
1997
|
1.14
|
|
10
|
Clinical stage IEA-IIEA orbital lymphomas: outcomes in the era of modern staging and treatment.
|
Radiother Oncol
|
2001
|
1.13
|
|
11
|
Long-term results with radiotherapy for Stage I-II follicular lymphomas.
|
Int J Radiat Oncol Biol Phys
|
2001
|
1.09
|
|
12
|
Allogeneic hematopoietic stem cell transplantation after rituximab-containing myeloablative preparative regimen for acute lymphoblastic leukemia.
|
Bone Marrow Transplant
|
2006
|
1.03
|
|
13
|
Postoperative radiotherapy for cutaneous melanoma of the head and neck region.
|
Int J Radiat Oncol Biol Phys
|
1994
|
1.01
|
|
14
|
Radiation-induced injury to the visual pathway.
|
Radiother Oncol
|
1994
|
0.98
|
|
15
|
Dequalinium, a topical antimicrobial agent, displays anticarcinoma activity based on selective mitochondrial accumulation.
|
Proc Natl Acad Sci U S A
|
1987
|
0.97
|
|
16
|
Rapid recovery of spermatogenesis after mitoxantrone, vincristine, vinblastine, and prednisone chemotherapy for Hodgkin's disease.
|
J Clin Oncol
|
1997
|
0.96
|
|
17
|
Nonnasopharyngeal lymphoepithelioma of the head and neck.
|
Cancer
|
1998
|
0.94
|
|
18
|
Protective effects of red ginseng saponins against carbon tetrachloride-induced hepatotoxicity in Sprague Dawley rats.
|
Planta Med
|
1997
|
0.94
|
|
19
|
Effects of 2-bromopropane on spermatogenesis in the Sprague-Dawley rat.
|
Reprod Toxicol
|
1999
|
0.89
|
|
20
|
Total body irradiation, fludarabine, melphalan, and allogeneic hematopoietic stem cell transplantation for advanced pediatric hematologic malignancies.
|
Bone Marrow Transplant
|
2006
|
0.88
|
|
21
|
Comparison of two total body irradiation fractionation regimens with respect to acute and late pulmonary toxicity.
|
Cancer
|
2001
|
0.88
|
|
22
|
Pretreatment of male BALB/c mice with beta-ionone potentiates thioacetamide-induced hepatotoxicity.
|
Toxicol Lett
|
1999
|
0.87
|
|
23
|
Subacute toxicity evaluation of a new camptothecin anticancer agent CKD-602 administered by intravenous injection to rats.
|
Regul Toxicol Pharmacol
|
2004
|
0.86
|
|
24
|
Primary parotid lymphoma: the effect of International Prognostic Index on outcome.
|
Leuk Lymphoma
|
1997
|
0.84
|
|
25
|
Primary non-Hodgkin lymphoma of the large bowel.
|
Radiology
|
1997
|
0.83
|
|
26
|
Stages I-III follicular lymphoma: role of CT of the abdomen and pelvis in follow-up studies.
|
Radiology
|
1999
|
0.81
|
|
27
|
Utilization of thermoluminescent dosimetry in total skin electron beam radiotherapy of mycosis fungoides.
|
Int J Radiat Oncol Biol Phys
|
1998
|
0.81
|
|
28
|
Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomas.
|
Int J Radiat Oncol Biol Phys
|
2000
|
0.81
|
|
29
|
Mechanism of destruction of Brugia malayi microfilariae in vitro: the role of antibody and leucocytes.
|
Acta Trop
|
1982
|
0.81
|
|
30
|
Immune status of various populations to hepatitis B virus in Singapore and a strategy for its prevention and immunoprophylaxis.
|
Dev Biol Stand
|
1983
|
0.80
|
|
31
|
Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma.
|
Cancer
|
2001
|
0.80
|
|
32
|
Purification and partial characterization of ring-shaped miniparticles.
|
Cell Biol Int Rep
|
1983
|
0.78
|
|
33
|
Mucosa-associated lymphoid tissue lymphoma with initial supradiaphragmatic presentation: natural history and patterns of disease progression.
|
Int J Radiat Oncol Biol Phys
|
2000
|
0.78
|
|
34
|
PET and SPECT imaging for stereotactic localization.
|
Stereotact Funct Neurosurg
|
1995
|
0.78
|
|
35
|
Recovery of sperm production following radiation therapy for Hodgkin's disease after induction chemotherapy with mitoxantrone, vincristine, vinblastine, and prednisone (NOVP).
|
Int J Radiat Oncol Biol Phys
|
2000
|
0.78
|
|
36
|
Radiation therapy after a partial response to CHOP chemotherapy for aggressive lymphomas.
|
Int J Radiat Oncol Biol Phys
|
2001
|
0.78
|
|
37
|
Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure.
|
Int J Radiat Oncol Biol Phys
|
2001
|
0.77
|
|
38
|
Subdiaphragmatic stage I & II Hodgkin's disease: long-term follow-up and prognostic factors.
|
Int J Radiat Oncol Biol Phys
|
1998
|
0.77
|
|
39
|
Multiple modality treatment of carcinoma cells with Pt(Rh-123)2 plus x-ray plus light.
|
Photochem Photobiol
|
1992
|
0.77
|
|
40
|
Role of metabolism in ethyl carbamate-induced suppression of antibody response to sheep erythrocytes in female Balb/C mice.
|
Int J Immunopharmacol
|
1995
|
0.77
|
|
41
|
Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to CHOP-based induction chemotherapy.
|
Int J Radiat Oncol Biol Phys
|
2001
|
0.77
|
|
42
|
Primary cutaneous non-Hodgkin's lymphoma of Ann Arbor stage I: preferential cutaneous relapses but high cure rate with doxorubicin-based therapy.
|
J Clin Oncol
|
2001
|
0.75
|
|
43
|
Three-dimensional treatment planning for central lymphatic irradiation.
|
Med Dosim
|
1999
|
0.75
|
|
44
|
Fludarabine-based preparative protocol for unrelated donor cord blood transplantation in children: successful engraftment with minimal toxicity.
|
Bone Marrow Transplant
|
1999
|
0.75
|
|
45
|
Correlation of gallium-67 SPECT and CT findings in primary gynecologic lymphoma.
|
Clin Imaging
|
1999
|
0.75
|
|
46
|
Highly active mesoporous chromium silicate catalysts in side-chain oxidation of alkylaromatics.
|
Dalton Trans
|
2012
|
0.75
|
|
47
|
A new concentrated perfluorochemical emulsion and carbogen breathing as an adjuvant to treatment with antitumor alkylating agents.
|
J Cancer Res Clin Oncol
|
1992
|
0.75
|
|
48
|
A 6-month subcutaneous toxicity study of recombinant human interferon alpha A (LBD-007) in Sprague-Dawley rats.
|
J Toxicol Sci
|
1993
|
0.75
|
|
49
|
Long-term outcome of treatment for Ann Arbor stage 1 Hodgkin's disease: patterns of failure, late toxicity and second malignancies.
|
Int J Radiat Oncol Biol Phys
|
1997
|
0.75
|
|
50
|
Selective synthesis of vitamin K3 over mesoporous NbSBA-15 catalysts synthesized by an efficient hydrothermal method.
|
Dalton Trans
|
2012
|
0.75
|
|
51
|
Radiation therapy for malignant lymphoma: enduring importance in the era of systemic therapy.
|
Biomed Pharmacother
|
2001
|
0.75
|
|
52
|
An acute toxicity study of recombinant human interferon alpha A (LBD-007) in Sprague-Dawley rats.
|
J Toxicol Sci
|
1993
|
0.75
|
|
53
|
Enhancing effects of captafol on the development of GST-P-positive liver cell foci in a medium-term bioassay, and protection by L-cysteine of the enhancement in rats.
|
Cancer Lett
|
1997
|
0.75
|
|
54
|
Selective synthesis of 6,8-di-t-butylated flavan over Zn-Al containing mesoporous silica catalysts.
|
Dalton Trans
|
2012
|
0.75
|
|
55
|
Stage I Hodgkin disease: radiation therapy and chemotherapy at the University of Texas M. D. Anderson Cancer Center, 1996-1997.
|
Radiology
|
1998
|
0.75
|
|
56
|
Reappraisal of eight representative carcinogenic and non-carcinogenic compounds in a new medium-term rat liver bioassay using D-galactosamine.
|
Cancer Lett
|
1996
|
0.75
|
|
57
|
Hodgkin's disease: correlation of clinical characteristics with probabilities for negative lymphangiogram vs. negative laparotomy findings in patients with Stage I supradiaphragmatic presentations vs. those in patients with Stage II.
|
Int J Radiat Oncol Biol Phys
|
1998
|
0.75
|
|
58
|
The outcome of combined-modality treatments for stage I and II primary large B-cell lymphoma of the mediastinum.
|
Int J Radiat Oncol Biol Phys
|
2000
|
0.75
|
|
59
|
Framework functionalization of periodic mesoporous organosilica with 1,2-bis[3-(triethoxysilylpropyl)ureido] cyclohexane function via basic co-condensation self-assembly.
|
J Nanosci Nanotechnol
|
2008
|
0.75
|
|
60
|
A 4-week subcutaneous toxicity study of recombinant human interferon alpha A (LBD-007) in Sprague-Dawley rats.
|
J Toxicol Sci
|
1993
|
0.75
|
|
61
|
Toxicity of repeated intravenous injection of gene therapeutics for X-CGD in mice.
|
Hum Exp Toxicol
|
2008
|
0.75
|